Todd C. Zion
Directeur Général chez Akston Biosciences Corp.
Profil
Todd C.
Zion was the founder of SmartCells, Inc. (founded in 2003) and Akston Biosciences Corp.
(founded in 2011), where he held the titles of President & Chief Executive Officer and Chairman, President & Chief Executive Officer, respectively.
He also worked as a Principal at Eastman Kodak Co. In terms of education, he received an undergraduate degree from Cornell University.
Postes actifs de Todd C. Zion
| Sociétés | Poste | Début |
|---|---|---|
Akston Biosciences Corp.
 Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | Directeur Général | 01/01/2011 |
Anciens postes connus de Todd C. Zion
| Sociétés | Poste | Fin |
|---|---|---|
| EASTMAN KODAK COMPANY | Corporate Officer/Principal | - |
SmartCells, Inc.
 SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Fondateur | - |
Formation de Todd C. Zion
| Cornell University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EASTMAN KODAK COMPANY | Producer Manufacturing |
| Entreprise privées | 2 |
|---|---|
SmartCells, Inc.
SmartCells, Inc. Medical SpecialtiesHealth Technology SmartCells, Inc. develops glucose-regulated smart insulin products for the treatment of diabetes. The company was founded by Todd C. Zion and James M. Herriman in 2003 and is headquartered in Beverly, MA. | Health Technology |
Akston Biosciences Corp.
Akston Biosciences Corp. Pharmaceuticals: MajorHealth Technology Akston Biosciences Corp. engages in the development of biologic therapeutics for use in autoimmune Type 1 diabetes prevention. It offers novel vaccine, disrupt insulin autoimmunity to prevent type 1 diabetes, and controlled hypoglycemia to enhance anti-tumor cancer therapy. The company was founded by Todd C. Zion in 2011 and is headquartered in Beverly, MA. | Health Technology |
